·
10 Min Read

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.

Advocacy Update
·
1 Min Read

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 20, 2023

In the news: Alarming spread of deadly and drug-resistant Candida auris fungus, growing drug shortages, autism spectrum disorder on the rise and more.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Feb. 13, 2023

In the news: children missing out on vital nutrition, early indicators of CVD and cognitive ability, COVID-19’s link to diabetes, FDA drug approvals and more.

Publications & Newsletters
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 9, 2023

In the news: Cancer mortality down 33%, duration of long COVID symptoms, dementia's link to hearing loss, FDA approval for Alzheimer’s drug and more.

Publications & Newsletters
People in conference room, seen through semi-opaque glass wall
·
4 Min Read

How the 10 largest PBMs hold huge sway in health care marketplace

First-of-its-kind data on pharmacy benefit managers (PBMs) analyzed in AMA report shows widespread, high market concentration.

Access to Care
UPDATED
·
2 Min Read

Prescription drugs: CSAPH reports

Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.

Science & Public Health
·
4 Min Read

AMA examines PBM market competition and integration with insurers

First-of-its-kind data assess national and local markets for commercial PBM services.

Press Releases
U.S. Capitol building
·
5 Min Read

Bill addresses 3 major health issues, but not Medicare pay reform

Inflation Reduction Act targets health insurance affordability, climate change and prescription drug costs—leaving Medicare pay reform for another day.

series
Access to Care
Fighting for Physicians